BackAVITA Medical Overview

AVITA Medical Receivables

AVITA Medical's receivables is $9.9M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$9.88M
↓ 18.63% YoYΔ $-2.26M vs prior year quarter

Peer average

Loading

AVITA Medical Receivables History

Loading

AVITA Medical vs. peers: Receivables Comparison

Loading

AVITA Medical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AVITA Medical (RCEL) FAQ

The latest receivables for RCEL is $9.9M as of March 2026. That compares with $12M in the prior-year period — down 18.6% year over year. Investors often review this figure alongside AVITA Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, RCEL's receivables moved from $12M to $9.9M — a 18.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AVITA Medical's operating scale or balance-sheet position.

A receivables figure of $9.9M for RCEL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RCEL's receivables ($9.9M), review year-over-year change from $12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.